New Research Identifies Negative Prognostic Factors in Mesothelioma, According to Surviving Mesothelioma
Raleigh, NC (PRWEB) February 24, 2016 -- Doctors in Ancona, Italy have confirmed the value of certain prognostic factors and added two of their own for predicting mesothelioma outcomes. Surviving Mesothelioma has just posted details of the new study. Click here to read their article now.
Scientists at Marche Polytechnic Institute analyzed the cases of 62 pleural mesothelioma patients over a ten-year period and found two factors closely associated with shorter mesothelioma survival.
“Our results showed that anemia and increased Ca125 might be considered negative prognostic parameters in malignant pleural mesothelioma patients,” writes author and oncologist Rossana Berardi, MD.
Anemia means that cells are not getting fully oxygenated and Ca125 is a protein found in higher concentrations in cancer cells.
“It’s impossible to make an effective treatment plan for mesothelioma unless you know where you stand,” says Alex Strauss, Surviving Mesothelioma’s Managing Editor. “Prognostic indicators help to do that. They offer a starting point.”
For a better understanding of prognosis in pleural mesothelioma, start with Prognostic Factors in Malignant Pleural Mesothelioma. now available on the Surviving Mesothelioma website.
Berardi, R, et al, “Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma”, February 12, 2016, Tumori, Epub ahead of print, http://www.ncbi.nlm.nih.gov/pubmed/26893272
For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.
Michael Ellis, Cancer Monthy, http://www.survivingmesothelioma.com, +1 (919) 570-8595, [email protected]
Share this article